Hydroxyphenylethanols

Hydroxyphenylethanols: Tyrosol and Hydroxytyrosol

1. Identity and Chemical Characterization

Hydroxyphenylethanols are a class of simple phenolic alcohols in which one or more hydroxyl groups are attached directly to a phenylethanol (phenethyl alcohol) scaffold. In the context of dietary supplements and nutritional science, the term refers primarily to two closely related compounds: tyrosol and hydroxytyrosol, which are the predominant representatives of this chemical family found in Olea europaea L. (the olive tree) and related food sources.

1.1 Tyrosol

Tyrosol — formally designated as 2-(4-hydroxyphenyl)ethanol, also known as (2-hydroxyethyl)phenol or p-hydroxyphenethyl alcohol (abbreviated TYR or Tyr) — is a monohydroxylated phenylethanol. It is a natural antioxidant widely present in the leaves and fruits of olive within the Oleaceae family. Tyrosol is a colorless solid at room temperature, melting at 91–92 °C, boiling at 158 °C at 4 Torr, and is slightly soluble in water.

1.2 Hydroxytyrosol

Hydroxytyrosol is an organic compound with the formula (HO)₂C₆H₃CH₂CH₂OH. It is also known as 4-(2-hydroxyethyl)-1,2-benzenediol, 3-hydroxytyrosol, or 2-(3,4-dihydroxyphenyl)ethanol (abbreviated HTYR or HT). It is a phenylethanoid — a relative of phenethyl alcohol — and is formally a derivative of catechol. The catechol (ortho-dihydroxy) moiety — the presence of two adjacent hydroxyl groups on the aromatic ring — distinguishes hydroxytyrosol structurally from tyrosol and is directly responsible for its markedly superior antioxidant capacity. Hydroxytyrosol is a colorless solid, although samples often turn beige during storage. It appears as a clear colorless liquid in purified form, exhibiting a solubility in water of 5 g per 100 mL at 25 °C.

1.3 Relationship Between the Two Compounds

Hydroxytyrosol and tyrosol are obtained through the hydrolysis of oleuropein, which is the main constituent that gives olives their bitter taste. This process of oleuropein hydrolysis occurs during olive ripening, storage, and processing. Hydroxytyrosol free form results from the hydrolytic activity of endogenous β-glucosidase during olive ripening, olive oil production, and storage over time. Critically, the two compounds are also metabolically interconverted in the human body: tyrosol is converted into hydroxytyrosol in vivo in humans, and cytochrome P450 enzymes CYP2A6 and CYP2D6 mediate this bioconversion.

2. Natural Sources and Botanical Origin

2.1 Primary Source: Olea europaea

Hydroxytyrosol is a plant-derived phenolic compound primarily found in Olea europaea L. products and by-products. It is notably present in extra virgin olive oil, as well as in olive by-products such as leaves and olive mill wastewater. In these matrices, it is mainly found in the form of secoiridoid derivatives, including oleuropein, its aglycone form, verbascoside, and oleacin.

Hydroxytyrosol and its derivatives occur in olives and in wines. The olives, leaves, and olive pulp contain large amounts of hydroxytyrosol derivative oleuropein, more so than olive oil.

The phenolic content of olive oil varies between 100 and 600 mg per kg, due to multiple factors — place of cultivation, climate, variety of the olive, and level of ripening at the time of harvest — with hydroxytyrosol and its derivatives providing half of that content. Hydroxytyrosol is one of the main phenolics found in extra virgin olive oil; its free form content varies from approximately 3.0 to 25.6 mg per kg.

2.2 Secondary Dietary Sources

Tyrosol is also found in beverages such as wine and beer, and hydroxytyrosol is present in red wine and is formed during digestion after consumption. Red wine is another natural source of hydroxytyrosol, and although the concentrations found are lower than those found in olive oil, bioavailability studies reveal the emergence of higher quantities of hydroxytyrosol concentrations than those administered in urinary recoveries after administration of red wine. An interaction between ethanol and dopamine leading to the formation of hydroxytyrosol was suggested as a possible explanation for this phenomenon.

A Mediterranean diet rich in olive oil supplies approximately 10–20 mg of phenols per day.

2.3 Industrial and Biotechnological Production

At present, hydroxytyrosol is mainly obtained by extraction from olive leaves, which has the disadvantages of high cost and occupation of a large amount of arable land. The biological synthesis of tyrosol and hydroxytyrosol has therefore become a research hotspot. Both natural and biotechnological synthesis routes have been explored, including enzyme-mediated, non-transgenic, and transgenic biosynthetic methods, with recent innovations that have improved yield and purity.

2.4 Common Forms and Preparations

Hydroxyphenylethanols are available in several commercial and research forms:

• High-phenolic extra virgin olive oil (HP-EVOO): The EFSA-approved health claim applies to olive oils with a minimum of 5 mg of hydroxytyrosol and its derivatives (oleuropein and tyrosol) per 20 g. High-phenolic EVOO is characterized by a minimum content of 250 mg of polyphenols per kg of oil.
• Olive leaf extract: When obtained as an extract of olive leaves, the extract will contain hydroxytyrosol, tyrosol, oleuropein, and other polyphenols. In one common embodiment, the hydroxytyrosol is obtained as an olive leaf extract of Olea europaea.
• Olive mill wastewater (vegetation water) extracts: Hydroxytyrosol may be obtained from olive fruits and from the vegetation water of olive oil production. This by-product stream can yield concentrated preparations.
• Purified hydroxytyrosol supplements: Standardized capsule, tablet, and powder forms are available, delivering measured quantities of isolated or semi-purified hydroxytyrosol. A gastroresistant capsule formulation containing 15 mg/day of hydroxytyrosol has been evaluated in clinical trials.
• Novel food preparations: In August 2024, China's National Health Commission approved hydroxytyrosol as a novel food additive, primarily for its antioxidant properties.

3. Historical and Traditional Use

3.1 The Mediterranean Dietary Tradition

The traditional Mediterranean diet, characterized by regular intake of olive oil, has been associated with many health-benefiting effects experienced by Mediterranean populations, including reduced incidence of different chronic degenerative diseases, major cardiovascular events, type 2 diabetes mellitus, and some types of cancer, as well as improved cognitive function.

Pharmacologists have been emphasizing and applying plant- and herbal-based treatments in vascular diseases for decades. Olives are a traditional symbol of the Mediterranean diet. The olive tree (Olea europaea) has been cultivated in the Mediterranean basin for more than 6,000 years, and both its fruit and leaf have featured in the traditional medicine of ancient Greek, Egyptian, and Middle Eastern cultures. Olive leaves were used in traditional Levantine medicine for fever reduction, and olive oil formed the cornerstone of dietary and topical practices across the ancient Mediterranean.

Olive oil is generally the main source of fat in the Mediterranean diet. Today, olive oil is synonymous with health, widely associated with many favorable effects, such as reduced incidence of different chronic diseases and prolonged longevity.

3.2 Isolation and Scientific Identification of the Compounds

While the olive tree's health associations have deep traditional roots, tyrosol and hydroxytyrosol were not isolated and identified as discrete chemical entities until the modern era. Their characterization as the principal low-molecular-weight phenolic fractions of olive oil occurred primarily in the latter half of the 20th century, with systematic investigation of their biological activities accelerating from the 1990s onward. These compounds are naturally recognized by the human body, and they do not present the adaptation problems encountered by other types of foreign polyphenol.

4. Key Constituents, Related Compounds, and Molecular Relationships

According to numerous investigations, the health-promoting effects of olive oil polyphenols are mostly attributable to the main secoiridoid derivatives such as oleuropein, oleocanthal, and oleacein, and the simple phenols hydroxytyrosol and tyrosol.

Within the hydroxyphenylethanols themselves, a key structural distinction governs biological potency:

• Tyrosol (monophenol): bears a single hydroxyl group at the para position of the aromatic ring. Tyrosol lacks the ortho-dihydroxy group and is consequently less effective than hydroxytyrosol as a direct radical scavenger in cell-based assays.
• Hydroxytyrosol (catechol/diphenol): bears two adjacent hydroxyl groups (catechol moiety). Its structure, which includes a catecholic moiety, is key to its potent antioxidant activity. This feature allows it to participate in redox cycles and oxidize to its corresponding catecholic quinone.

Virgin olive oils and extra virgin olive oils contain 97–99% lipids, mostly triglycerides, and 1–3% of minor components including phenolic compounds derived from oleuropein and ligstroside, among which hydroxytyrosol and tyrosol are prominent. Higher-molecular-weight secoiridoids (oleuropein, oleocanthal, oleacein) serve as precursors that release tyrosol and hydroxytyrosol upon hydrolysis during digestion or processing. The polyphenols specifically mentioned by EFSA are hydroxytyrosol, tyrosol, and further complex polyphenols of high molecular mass from which they can be derived, known as secoiridoids.

Hydroxytyrosol also exists in nature as esters and conjugates: hydroxytyrosol is widely present in the leaves and fruits of olive in the form of esters, and is one of the natural antioxidants. Its acetate ester (hydroxytyrosol acetate) and various lipophilic derivatives have been studied for enhanced bioavailability.

5. Mechanisms of Action

5.1 Direct Antioxidant Activity (Radical Scavenging)

Hydroxytyrosol has a potent antioxidant effect related to hydrogen donation and the ability to improve radical stability. It has been suggested that hydroxytyrosol can act as a scavenger of reactive free radicals and in this way protect cells under conditions of oxidative stress. When compared to other natural antioxidants such as ascorbic acid, glutathione, and vitamin E, hydroxytyrosol demonstrates superior antioxidant activity.

The main phenolic alcohols of olive oil, hydroxytyrosol and tyrosol, were examined for their ability to protect cultured cells under conditions of oxidative stress. A strong correlation was observed between the ability of hydroxytyrosol to mitigate intracellular labile iron level and the protection offered against H₂O₂-induced DNA damage and apoptosis.

5.2 Nrf2/HO-1 Pathway Activation (Indirect Antioxidant)

Hydroxytyrosol exhibits a protective effect on the organism as it induces the production of antioxidant enzymes through modulation of the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway. Hydroxytyrosol can induce the expression of antioxidant enzymes via Nrf2 activation, reduce expression of cell adhesion molecules, inhibit platelet aggregation, and exert anti-inflammatory and anti-cancer effects. Western blot studies have demonstrated increased expression of Nrf2 and HO-1 with hydroxytyrosol treatment, indicating that it restores anti-oxidant potential via induction of the Nrf2/HO-1 signaling pathway.

5.3 NF-κB Inhibition and Anti-Inflammatory Signaling

Hydroxytyrosol has demonstrated the ability to inhibit the generation of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6 by reducing the activation of NF-κB and other inflammation-related signaling pathways. This anti-inflammatory impact is reinforced by its ability to decrease oxidative stress, which is closely connected to inflammatory reactions. In macrophage cell models, hydroxytyrosol suppressed NF-κB signaling and downregulated LPS-mediated expression of iNOS, cyclooxygenase-2, TNF-α, and IL-1β, resulting in reduced production of nitric oxide and prostaglandin E2.

5.4 Endothelial and Vascular Mechanisms

Hydroxytyrosol activates the PI3K/AKT/mTOR and Nrf2/HO-1 pathways, promoting re-endothelialization and decreasing oxidative stress; inhibits TGF-β-induced endothelial-to-mesenchymal transition; regulates reverse cholesterol transport by increasing ABCA1 and decreasing FMO3; suppresses oxidative stress by activation of SIRT1; lowers platelet aggregation by suppressing adhesion molecules; inhibits NF-κB-induced ROS, which subsequently triggers the production of pro-inflammatory cytokines and adhesion molecules; and inhibits the production of pro-inflammatory cytokines and adhesion molecules that promote atherosclerosis.

5.5 Inhibition of LDL Oxidation

The olive oil phenolic hydroxytyrosol prevents low-density lipoprotein (LDL) oxidation, platelet aggregation, and inhibits 5- and 12-lipoxygenases. This mechanism is the specific basis for the EFSA-approved cardiovascular health claim.

5.6 Mitochondrial Function

Treatment with hydroxytyrosol attenuated the TNF-α-induced downregulation of mitochondrial biogenesis by increasing PGC-1α, mitochondrial complexes I and II, and myogenin expression, indicating that hydroxytyrosol improves mitochondrial development and function in muscle cells under inflammatory stress.

6. Scientific Evidence by Area of Use

6.1 Cardiovascular Health and LDL Oxidation Protection

This is the area with the strongest and most formally evaluated human evidence for hydroxyphenylethanols.

The European Food Safety Authority (EFSA) issued a scientific opinion on health claims in relation to dietary consumption of hydroxytyrosol and related polyphenol compounds from olive fruit and oil and the protection of blood lipids from oxidative damage, which is known to adversely affect cardiovascular health (EFSA Journal 2011;9(4):2033).

On the basis of the data presented, EFSA concluded that a cause-and-effect relationship has been established between the consumption of hydroxytyrosol and related compounds from olives and olive oil and protection of blood lipids from oxidative damage. In weighing the evidence, EFSA took into account a well-designed-and-conducted study and two smaller-scale studies that showed a dose-dependent and significant effect.

Well-designed studies contributing to EFSA's claim of hydroxytyrosol as an antioxidant compound for circulating LDL include the multicenter work of Covas et al. in 2006, in which 200 healthy male volunteers were randomly assigned to three sequences of daily administration of 25 mL of three different olive oils containing 2.7 mg, 164 mg, or 366 mg per kg of oil of phenolic compounds.

In a randomized double-blinded, placebo-controlled crossover trial examining purified supplements: 15 mg per day of hydroxytyrosol consumption was observed to exert positive effects on human health, reducing oxidative stress and cardiovascular risk and improving lipid and plasma antioxidant profile, although this daily amount of hydroxytyrosol did not appear to produce positive effects on oxidized LDL-C. The trial used two gastroresistant capsules containing 15 mg/day of hydroxytyrosol for a 3-week period in healthy volunteers, evaluating nutritional status, serum metabolites, oxidative stress biomarkers, and gene expression of genes related to oxidative stress, inflammation, and cardiovascular disease.

A trial specifically examining EVOO rich in tyrosol and hydroxytyrosol in elderly post-myocardial infarction patients: all participants consumed 25 mL per day for a duration of 26 weeks, a dose selected based on previous clinical trials demonstrating efficacy in improving cardiovascular and oxidative stress markers.

Ingestion of tyrosol and its conversion into hydroxytyrosol have been found to improve endothelial function, and to improve HDL cholesterol, vasodilatory, and inflammatory markers in a randomized controlled trial.

Evidence strength: Moderate-to-strong for LDL oxidation protection (sufficient for an EFSA-approved health claim with a defined minimum dose). Notably, all reported benefits observed in reviewed trials were from short-term studies; EFSA considers a minimum of eight weeks the necessary duration to demonstrate stable effects on blood lipids or blood pressure. Evidence for broader cardiovascular endpoints (e.g., systolic blood pressure reduction, HDL maintenance) remains preliminary. Under the highest scientific standards, sufficient human evidence to confirm a cause-and-effect relationship for lowering LDL cholesterol or systolic blood pressure has not yet been established.

6.2 Antioxidant Status and Oxidative Stress Biomarkers

Around 98% of hydroxytyrosol administered was metabolized into sulphate conjugates or glucuronides, and only 2% was found free in urine and plasma. Hydroxytyrosol reaches maximum plasma concentration in seven minutes and has a 1–2 minute half-life. A randomized human trial revealed that hydroxytyrosol from virgin olive oil becomes part of high-density lipoproteins more rapidly and exhibits antioxidant and cardioprotective properties.

After intake of hydroxytyrosol-containing products, hydroxytyrosol was excreted in the urine by a majority of subjects, confirming product uptake.

Evidence strength: Established for short-term improvement in circulating antioxidant markers in humans; largely based on biomarker studies and smaller randomized trials rather than hard clinical endpoints.

6.3 Neuroprotection and Cognitive Function

Hydroxytyrosol is a powerful antioxidant whose consumption offers several health effects including neuroprotection and cognitive health. It is associated with neuroprotective effects, which have prompted research into its potential to prevent cognitive decline, particularly in relation to Alzheimer's disease.

The lower incidence of Alzheimer's disease in countries featuring the Mediterranean diet was associated with the high consumption of extra virgin olive oil and its polyphenolic fraction, in particular hydroxytyrosol.

In animal research, one preclinical study assessed whether neuroprotective and anti-inflammatory effects from oleuropein aglycone administration were reproduced by diet supplementation with similar amounts of its metabolite hydroxytyrosol. Four-month-old TgCRND8 (Alzheimer's model) and wild-type mice were treated for 8 weeks with a low-fat diet (5%) supplemented with hydroxytyrosol (50 mg/kg of diet).

3-Hydroxytyrosol was identified for the first time as a cholinesterase inhibitor with significant in vivo antiamnesic activity in a multimethodological screening study, warranting further investigation.

Multiple studies indicate that the antioxidant properties of hydroxytyrosol help mitigate oxidative stress and inflammation, two key factors in the progression of neurodegenerative diseases like Alzheimer's. Consumption of olive oil rich in hydroxytyrosol has been associated with improved cognitive performance in older adults, highlighting its neuroprotective effects and suggesting that regular dietary intake can have a substantial impact on maintaining cognitive health in aging populations.

Evidence strength: Preliminary. Evidence is largely epidemiological (Mediterranean diet studies), in vitro, and animal-model based. Dedicated, adequately powered human clinical trials for neurological endpoints are lacking, and causality has not been established for hydroxytyrosol as an isolated compound.

6.4 Antidiabetic and Metabolic Effects

Hydroxytyrosol is a phenolic phytochemical found in olive leaves and olive oil reported to have antioxidant, anti-inflammatory, anticancer, and antidiabetic properties. Multiple in vitro and in vivo studies have examined its antidiabetic properties and investigated the mechanisms of action.

Previous research has shown that hydroxytyrosol has beneficial effects in preventing oxidative stress, inflammation, hyperglycemia, and hyperlipidemia. Mechanisms under investigation include improvement of insulin sensitivity, reduction of gluconeogenesis, and mitochondrial biogenesis in skeletal muscle. Treatment of C2C12 muscle cells with hydroxytyrosol (1–50 µM) increased creatine kinase activity and myosin heavy chain expression, which are indicators of muscle cell differentiation and strength of contraction, demonstrating a possible improvement in muscle adaptation to exercise.

Evidence strength: Preclinical only at this stage. The existing body of human evidence for direct antidiabetic endpoints (e.g., fasting glucose, HbA1c) in isolation from general Mediterranean diet adherence is insufficient to draw firm conclusions.

6.5 Antimicrobial and Antiviral Effects

Due to its molecular structure, hydroxytyrosol's regular consumption has been associated with antioxidant, anti-inflammatory, antidiabetic, antimicrobial, and anticancer effects, as well as protective actions for the skin and eyes.

Hydroxytyrosol has been described as a phytochemical with several biological properties, particularly anti-inflammatory, as well as antibacterial, antiviral, and antimycotic activity. Its established range of biological effects includes anti-inflammatory, anticancer, antiviral, cardioprotective, neuroprotective, and antibacterial properties.

Evidence strength: Primarily in vitro. Minimum inhibitory concentration data against bacteria, fungi, and certain viruses have been generated in cell and culture models. Direct human clinical evidence for antimicrobial benefits as a dietary supplement is not yet established.

6.6 Anticancer Properties

Studies of the anticancer properties of hydroxytyrosol in human differentiated thyroid carcinoma showed that hydroxytyrosol increased apoptosis via activation of the mitochondrial apoptotic mechanism in papillary and follicular cancer cells. Concurrently, strong resistance of thyroid cancer cells to hydroxytyrosol was shown, with higher doses needed for a similar antiproliferative effect compared to some other types of cancer cells (e.g., colon or breast).

The synthesis of ester, ether, and thio derivatives of hydroxytyrosol with increased lipophilic character to increase bioavailability, as a basis for the creation of new pharmacological agents for cancer prevention and therapy, has been reviewed, taking into account studies performed in several experimental cell-based models.

Hydroxytyrosol has been used in trials studying the prevention of breast cancer.

Evidence strength: Preliminary; primarily in vitro and animal models. Published human intervention trials specifically examining hydroxytyrosol as an isolated anticancer agent are limited, and no conclusions about cancer prevention or treatment in humans can be drawn from the available data.

6.7 Gastrointestinal and Hepatic Effects

Studies have shown that tyrosol and oleocanthal — and related compounds — can potentially mitigate chronic liver diseases such as metabolic-associated steatotic liver disease (MASLD) and liver fibrosis, as well as their progression to liver cancer, through regulation of cellular pathways involved in antioxidant response, lipid metabolism, transcription factor activity, and NF-κB signaling.

Olive leaf extract rich in oleuropein, oleuropein aglycone, and hydroxytyrosol lowered serum total cholesterol, triglycerides, and LDL cholesterol levels and increased HDL cholesterol levels, slowed down the lipid peroxidation process, and enhanced antioxidant enzyme activity in Wistar rats. Oleuropein — the major glycosidic precursor of hydroxytyrosol — exerted a protective effect on progression of non-alcoholic steatohepatitis to fibrosis in a mouse model.

Evidence strength: Predominantly preclinical (animal models and in vitro). Limited controlled human data exist specifically for gastrointestinal or hepatic endpoints of isolated hydroxyphenylethanols.

7. Bioavailability and Metabolism

When consumed, extra virgin olive oil's phenolic compounds are hydrolyzed in the stomach and intestine, increasing levels of free hydroxytyrosol, which is then absorbed in the small intestine, forming phase II metabolites.

An in vitro study in Caco-2 cells showed that hydroxytyrosol is transported via passive diffusion in a dose-dependent manner. A human study also showed that tyrosol and hydroxytyrosol are excreted in urine. These results suggest that these simple olive oil phenols are absorbed in the intestine after ingestion.

Around 98% of hydroxytyrosol administered was metabolized into sulfate conjugates or glucuronides; only 2% was found free in urine and plasma. Hydroxytyrosol reaches maximum plasma concentration in seven minutes and has a 1–2 minute half-life.

The gut microbiota modulates the structure, bioavailability, and bioactivity of these phenolic compounds, thereby influencing their therapeutic potential. Gut microbial metabolism can magnify or alter the biological effects of tyrosol and hydroxytyrosol, and interindividual differences in microbiota composition may influence their efficacy.

Due to its high hydrophilicity, hydroxytyrosol exhibits unfavorable pharmacokinetic properties that may prevent its potential therapeutic use at higher doses. Various strategies can be employed to address these limitations. Research into lipophilic derivatives (e.g., hydroxytyrosol acetate, hydroxytyrosol butyrate) and encapsulation technologies is ongoing with the aim of improving oral bioavailability.

An important metabolic consideration is the in vivo bioconversion of tyrosol to hydroxytyrosol: beer and wine contain the simple phenol tyrosol, which is endogenously converted into hydroxytyrosol, one of the strongest dietary antioxidants, by CYP2A6 and CYP2D6 polymorphic enzymes. In a single-blind, randomized, crossover, controlled clinical trial in 20 healthy subjects, this bioconversion was evaluated after ingestion of red wine, Indian pale ale beer, blonde beer, and non-alcoholic beer.

8. Body Systems and Health Areas

Based on the totality of in vitro, animal, and human evidence, hydroxyphenylethanols have been studied in relation to the following body systems and health domains:

• Cardiovascular system: Hydroxytyrosol and tyrosol present in extra virgin olive oil confer cardioprotection through antioxidant, anti-inflammatory, and metabolic regulatory mechanisms. Specific studied endpoints include LDL oxidation, endothelial function, platelet aggregation, blood pressure, and HDL functionality.
• Central nervous system: The multifaceted biological activities of hydroxytyrosol include its role in cardiovascular protection and neuroprotection. Research targets include Alzheimer's disease, Parkinson's disease, and general age-related cognitive decline.
• Metabolic and endocrine system: Tyrosol has been reported to have a role in prevention of cardiovascular diseases, osteopenia, and melanin pigmentation. Hydroxytyrosol has been studied for effects on insulin sensitivity, glucose metabolism, and lipid profiles.
• Gastrointestinal and hepatic systems: Hydroxytyrosol provides anti-steatotic properties and improvement in endoplasmic reticulum stress, autophagy, and mitochondrial function.
• Immune and inflammatory systems: Hydroxytyrosol is the major anti-inflammatory compound in aqueous olive extracts and impairs cytokine and chemokine production in macrophages.
• Skin and eye protection: Hydroxytyrosol has been studied for eye and skin protective properties in addition to its cardioprotective, anticancer, neuroprotective, and antibacterial effects.
• Skeletal system: Hydroxytyrosol has been reported to help prevent osteopenia, in addition to its cardiovascular benefits.

9. Dosage Forms and Doses Reported in Studies

The following dosages are reported directly from referenced sources and should not be interpreted as prescriptive recommendations:

• EFSA-defined minimum for cardiovascular health claim: A minimum of 5 mg of hydroxytyrosol and its derivatives in olive oil should be consumed daily to use a cardiovascular health claim.
• EFSA oil concentration threshold: The European Food Safety Authority authorized a health claim for olive oil containing at least 250 mg per kg of polyphenols.
• Covas et al. multicenter trial (2006): 200 healthy male volunteers received 25 mL daily of three different olive oils containing 2.7 mg, 164 mg, or 366 mg per kg of oil of phenolic compounds.
• Randomized crossover purified supplement trial: Two gastroresistant capsules containing 15 mg/day of hydroxytyrosol for a 3-week period were evaluated in healthy volunteers.
• Tyrosol conversion trial: A randomized, crossover, controlled clinical trial with 33 individuals at cardiovascular risk involved white wine supplemented with tyrosol capsules (25 mg per drink), with intervention periods of 4 weeks preceded by three-week washout periods.
• EVOO trial in post-MI elderly patients: All participants consumed 25 mL per day for a duration of 26 weeks.
• Phase II enzyme induction pilot study (ClinicalTrials.gov): A randomized crossover pilot study examined the effects of two doses of hydroxytyrosol: 5 mg/day and 25 mg/day, for one week each with a one-week washout period.
• EFSA novel food safety assessment (90-day rat study): Hydroxytyrosol was tested at dose levels of 5, 50, or 500 mg per kg body weight per day in a subchronic 90-day oral toxicity study in rats.
• Mouse Alzheimer's model: Mice were treated for 8 weeks with a low-fat diet supplemented with hydroxytyrosol at 50 mg/kg of diet.

10. Safety Considerations and Interactions

10.1 Regulatory Safety Status

The EFSA Panel on Dietetic Products, Nutrition and Allergies has concluded that hydroxytyrosol is safe under the proposed uses and use levels as a novel food under Regulation (EC) No 258/97.

Considering the no-observed-adverse-effect level (NOAEL) of 50 mg per kg body weight per day from a subchronic oral toxicity study and the maximum anticipated daily intake, the margin of exposure would result in a factor of 100 for children (3–9 years) and at least 200 for adolescents, adults (excluding pregnant and breastfeeding women), and elderly.

The anticipated daily intake of hydroxytyrosol as a novel food would be in the range of, or even less than, the exposure of hydroxytyrosol from the consumption of olive oils and olives, which has not been associated with adverse effects.

Safety assessments from animal and human studies demonstrate low toxicity and favorable metabolic profiles at physiologically relevant doses. It has been demonstrated that hydroxytyrosol consumption is safe even at high doses and is not genotoxic or mutagenic in vitro.

Based on studies provided to the EFSA panel, there is no concern with regard to potential genotoxicity.

The target population for the approved novel food use is the general population, which excludes children under 36 months of age, pregnant women, and breastfeeding women.

10.2 Platelet Aggregation and Anticoagulant Interactions

Hydroxytyrosol prevents platelet aggregation, which represents both a mechanistic benefit for cardiovascular protection and a theoretical source of interactions. Phenolic compounds can affect platelet activation pathways. While clinical bleeding events are not well documented with typical doses, caution is warranted with concurrent use of aspirin, clopidogrel, warfarin, or direct oral anticoagulants (DOACs).

10.3 Blood Pressure Interactions

By supporting endothelial function and vascular tone, hydroxytyrosol may reinforce blood pressure medications in sensitive individuals.

10.4 Anti-inflammatory Drug Interactions

Hydroxytyrosol's anti-inflammatory effects may theoretically enhance or interact with NSAID medications and anticoagulants. No serious interactions have been documented in published clinical trials.

10.5 Bioavailability-Modifying Factors

Hydroxytyrosol absorption rates vary according to the vehicle used; olive oil has been shown to support more efficient absorption. The food matrix in which hydroxyphenylethanols are consumed therefore influences effective exposure.

10.6 Evidence Limitations and Gaps

The available evidence concludes that these phenolic compounds have great pharmacological potential; however, further studies are still required. The effects of hydroxytyrosol on endothelial functioning have not been extensively studied, limiting its value either as a nutraceutical supplement or in clinical trials. Current challenges associated with application include low bioavailability and long-term safety concerns, and further investigation in these areas has been proposed.

Many studies to date have been short in duration, involved small populations, used olive oil (a complex food matrix) rather than isolated compounds, or were conducted in vitro or in animal models. These methodological factors limit the transferability of findings to conclusions about isolated hydroxyphenylethanols as dietary supplements.

References

• Karković Marković A, et al. (2019). Hydroxytyrosol, Tyrosol and Derivatives and Their Potential Effects on Human Health. Molecules. PMC6571782.
• Virruso C, et al. (2020). Wide Biological Role of Hydroxytyrosol: Possible Therapeutic and Preventive Properties in Cardiovascular Diseases. PMC7565717.
• Vlavcheski F, Young M, Tsiani E. (2019). Antidiabetic Effects of Hydroxytyrosol: In Vitro and In Vivo Evidence. Antioxidants. PMC6616959.
• From Biosynthesis to Legislation: A Review of Hydroxytyrosol's Biological Functions and Safety. (2025). PMC12111773.
• Hydroxytyrosol: A Promising Therapeutic Agent for Mitigating Inflammation and Apoptosis. (2024). PMC11728517.
• Effects of Hydroxytyrosol in Endothelial Functioning: A Comprehensive Review. (2023). PMC9966213.
• Hydroxytyrosol and Its Potential Uses on Intestinal and Gastrointestinal Disease. (2023). PMC9964144.
• Antioxidant Effects of a Hydroxytyrosol-Based Pharmaceutical Formulation on Body Composition, Metabolic State, and Gene Expression: A Randomized Double-Blinded, Placebo-Controlled Crossover Trial. (2017). PMC5569630.
• Data on the endogenous conversion of tyrosol into hydroxytyrosol in humans. (2019). PMC6880089.
• Covas MI, et al. Cardiovascular benefits of tyrosol and its endogenous conversion into hydroxytyrosol in humans. A randomized, controlled trial. Free Radical Biology and Medicine. ScienceDirect.
• Hydroxytyrosol Exerts Anti-Inflammatory and Anti-Oxidant Activities in a Mouse Model of Systemic Inflammation. (2019). PMC6321432.
• Hydroxytyrosol inhibits hydrogen peroxide-induced apoptotic signaling via labile iron chelation. PMC5094689.
• Hydroxytyrosol and Cytoprotection: A Projection for Clinical Interventions. (2017). PMC5454843.
• Anti-inflammatory effects of olive-derived hydroxytyrosol on lipopolysaccharide-induced inflammation in RAW264.7 cells. PMC6305503.
• Metabolism and Bioavailability of Olive Bioactive Constituents Based on In Vitro, In Vivo and Human Studies. (2022). PMC9504511.
• Hydroxytyrosol: biological activities and potential application in livestock production. (2025). PMC12682646.
• Impact of pharmacokinetic enhancement strategies on the antimicrobial and antioxidant activities of hydroxytyrosol. (2025). PMC11789759.
• Polyphenol-Microbiota Interactions in Atherosclerosis: The Role of Hydroxytyrosol and Tyrosol. (2025). PMC12694252.
• Novel Ingredients: Hydroxytyrosol as a Neuroprotective Agent; What Is New on the Horizon? (2025). PMC12608587.
• EFSA Panel on Dietetic Products, Nutrition and Allergies. Safety of hydroxytyrosol as a novel food pursuant to Regulation (EC) No 258/97. PMC7010075.
• Beneficial Effects of Tyrosol and Oleocanthal from Extra Virgin Olive Oil on Liver Health: Insights into Their Mechanisms of Action. (2024). PMC11504303.
• Production of biologically active hydroxytyrosol rich extract via catalytic conversion of tyrosol. (2022). PMC8979270.
• Hydroxytyrosol and Brain Tumors: Mechanisms of Action and Therapeutic Potential. (2025). PMC12384330.
• 3-Hydroxytyrosol as a phenolic cholinesterase inhibitor with antiamnesic activity. (2025). PMC12537693.
• Hydroxytyrosol and Potential Uses in Cardiovascular Diseases, Cancer, and AIDS. Frontiers in Nutrition. (2014).
• Olive Oil Phenols Are Absorbed in Humans. Journal of Nutrition. ScienceDirect.
• Role of Hydroxytyrosol and Oleuropein in the Prevention of Aging and Related Disorders. Nutrients. (2023).
• Diet Supplementation with Hydroxytyrosol Ameliorates Brain Pathology and Restores Cognitive Functions in a Mouse Model of Amyloid-β Deposition. PubMed.
• Tyrosol and hydroxytyrosol: Current insights into biosynthesis, nutraceutical versatility, and human health. ScienceDirect (2026).
• Olive oil varieties and ripening stages containing hydroxytyrosol and derivatives in compliance with EFSA health claim. Food Chemistry. (2021).
• Human Study of Hydroxytyrosol on Phase II Enzymes in Healthy Subjects. ClinicalTrials.gov NCT02273622.
• High-Tyrosol/Hydroxytyrosol Extra Virgin Olive Oil Enhances Antioxidant Activity in Elderly Post-Myocardial Infarction Patients. Antioxidants. (2025).
• Exploring the Benefits of Extra Virgin Olive Oil on Cardiovascular Health Enhancement and Disease Prevention: A Systematic Review. (2025). PMC12158199.
• From Biosynthesis to Legislation: A Review of Hydroxytyrosol's Biological Functions and Safety. International Journal of Molecular Sciences. (2025).
• Hydroxytyrosol — Wikipedia (for chemical identity reference).